First case of Covid BF.7 variant confirmed in Karachi

• BF.7 symptoms include fever, sore throat
• Dow sent its genomic survey that confirmed case
• Variant appears to be stable outside China

KARACHI: First case of Covid-19’s variant BF.7 has been confirmed in Karachi, Bol News reported on Tuesday.

Dow University of Health Sciences sent its genomic survey that confirmed one case of BF.7.

BF.7 symptoms include fever, sore throat, runny nose, fatigue, vomiting, and diarrhoea.

Despite the immune-evasive properties of BF.7 and the alarming indications of its expansion in China, the variant appears to be rather stable elsewhere. For instance, it was predicted to account for 5.7% of illnesses in the US up until December 10, 2022, a decrease from 6.6% the week before.

Also Read

NIH registered 17 new COVID-19 cases

No death occurred due to coronavirus in last 24 hours. 4,462 tests...

A lack of immunity in China from the prior infection and potentially vaccination may be a contributing factor in the Chinese predicament and BF.7’s high reproduction rate.

The most recent research indicates that BF.7 transmits more quickly than previous variants. It can infect persons more easily who have already had COVID-19 infection or even those who have had vaccinations because to its shorter incubation time.

On January 28,  National Institute of Health (NIH), Islamabad had recorded 17 new cases of COVID-19 during the last 24 hours while no death had occurred due to corona.

According to the details, the NIH report had stated that 4,462 coronavirus tests had been conducted across the country in the last 24 hours, in which 17 new cases of corona had been reported and the rate of positive cases of the Covid was 0.38 percent. . While the condition of 10 patients affected by Coronavirus was said to be critical.

The Director General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, had warned that the threat of a new type of coronavirus continued, but the current situation regarding care management, vaccines and treatment was better compared to 2019.